Sctm130126 98..107

J. V. D. Beucken,Jinling Ma,S. Both,Fang Yang,F. Cui,J. Pan,G. Meijer

2013-01-01

Abstract:Cellular strategies play an important role in bone tissue engineering and regenerativemedicine (BTE/ RM). Variability in cell culture procedures (e.g., cell types, cell isolation and expansion, cell seeding methods, and preculture conditions before in vivo implantation) may influence experimental outcome. Meanwhile, outcomes from initial clinical trials are far behind those of animal studies, which is suggested to be related to insufficient nutrient and oxygen supply inside the BTE/RM constructs as some complex clinical implementations require bone regeneration in too large a quantity. Coculture strategies, in which angiogenic cells are introduced into osteogenic cell cultures, might provide a solution for improving vascularization andhence increasingbone formation for cell-based constructs. So far, preclinical studies have demonstrated that cell-based tissue-engineered constructs generally inducemore bone formation comparedwith acellular constructs. Further, cocultures have been shown toenhancevascularizationandbone formation comparedwithmonocultures.However, translational efficacy from animal studies to clinical use requires improvement, and the role implanted cells play in clinical bone regeneration needs to be further elucidated. In view of this, the present reviewprovides an overviewof the critical procedures during in vitro and in vivo phases for cell-based strategies (both monoculture and coculture) in BTE/RM to achieve more standardized culture conditions for future studies, and hence enhance bone formation. STEMCELLS TRANSLATIONALMEDICINE 2014;3:98–107